# Protalix BioTherapeutics, Inc.: Form DEF 14A, filed Jun 4, 2021

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: DEF 14A
- Filed: 2021-06-04
- Accepted by EDGAR: Jun 4, 2021, 16:30 ET
- Period: 2021-07-07
- Accession: 0001558370-21-008019
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837021008019/tmb-20210707xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837021008019/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837021008019/tmb-20210707xdef14a.htm

Filed Jun 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-008019. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
